{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"condition":["BRAF V600E-mutant Metastatic Colorectal Cancer"],"disease":["Braf V600e-mutant Metastatic Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2655825"],"location":["Japan"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and Safety of FOLFOXIRI plus Bevacizumab and Doublet plus Biologics in Patients With Previously Untreated BRAF V600E-mutant Metastatic Colorectal Cancer: A Multi-institutional retrospective study (WJOG13219G)","description":"Primary outcome(s): Overall survival","dates":{"creation":"2020-12-15"},"accession":"2655825","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000041098"]}}